Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) Proposed Rule (CMS-6098-P)

On Nov. 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would strengthen program integrity (PI) oversight and the agency’s ability to prevent, identify, and address fraud, waste, and abuse across Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Health Insurance Marketplace.

The Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) proposed rule is a standalone, discretionary rule rather than an annual payment rule. It proposes changes to provider and supplier enrollment requirements; Medicare Advantage (MA) and Medicare Part D oversight; Medicaid and CHIP program integrity and eligibility oversight; Medicare durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) supplier requirements; and Marketplace agent and broker oversight. CMS intends to conduct program integrity rulemaking of this kind on an annual basis going forward.

Background

On Feb. 27, 2026, CMS issued a Request for Information (RFI) (91 FR 9803) seeking public input on regulatory changes that could help the agency more effectively prevent, identify, and address fraud, waste, and abuse and protect taxpayer dollars across its programs. CMS received over 560 comments and suggestions in response to the RFI, some of which informed the provisions of this proposed rule.

This proposed rule supports Administration priorities on program integrity oversight, including the June 6, 2025, Presidential Memorandum on Eliminating Fraud, Waste, and Abuse in Medicaid, and Executive Order 14395, which established the White House Task Force to Eliminate Fraud.

Medicare Provider Enrollment and Oversight

Faster Reporting of Enrollment Changes

Under current regulations, providers and suppliers generally have 30 calendar days to report critical changes to their Medicare enrollment information (such as changes in practice location, ownership, or adverse legal actions) and up to 90 calendar days to report other types of changes. CMS is proposing to require that all providers and suppliers report any change to their enrollment information within 30 calendar days, regardless of the type of change or the type of provider or supplier involved. CMS believes this accelerated timeline will improve the agency’s ability to prevent, identify, and address fraud, waste, and abuse.

New Grounds for Medicare Enrollment Denial and Revocation

CMS is proposing to add a new ground for denial or revocation that would apply when a provider or supplier has a domestic or foreign owner, managing employee, organization, partner, officer, or director whose identity cannot be confirmed, or whom CMS determines poses an undue risk of fraud, waste, and abuse. CMS believes this new authority would help prevent bad actors from enrolling in, or remaining in, the Medicare program.

Medicare Advantage and Part D Program Integrity

Mandatory Fraud, Waste, and Abuse Reporting

CMS currently encourages, but does not require, MA organizations and Part D plan sponsors to report referrals of substantiated or suspicious fraud, waste, and abuse. In addition, CMS requires reporting of inappropriate prescribing of opioids and payment suspensions for pharmacies based on credible allegations of fraud but does not require reporting of payment suspensions based on credible allegations of fraud for other provider or supplier types. For calendar year 2025, CMS determined, through its review of a frequency report, only 46% of Medicare Part C and Part D plan contracts voluntarily reported referrals of substantiated or suspicious fraud, waste, and abuse to CMS and only 19% of Medicare Part C and Part D plan contracts reported any payment suspensions based on credible allegations of fraud to CMS, including both pharmacies and other provider and supplier types. CMS is proposing to make referrals by MA organizations and Part D plan sponsors to CMS of substantiated or suspicious fraud, waste, and abuse mandatory and to expand MA organization and Part D plan sponsor reporting of payment suspensions based on credible allegations of fraud by pharmacies to all provider and supplier types. This proposal is also consistent with a July 2018 Office of Inspector General (OIG) recommendation that CMS require plan sponsors to report Part C and D fraud and abuse incidents and corrective actions to a centralized system.

Medicare Advantage Provider Enrollment in Fee-for-Service Medicare

Current regulations do not generally require providers and suppliers who bill MA plans to also be enrolled in Original Medicare. CMS currently relies on a preclusion list as an alternative screening mechanism, but this list operates reactively, after a provider has already begun billing MA plans, rather than screening providers before they begin furnishing services. CMS is proposing to add a requirement, at proposed § 422.222(a), that all eligible providers and suppliers billing MA be enrolled in Original Medicare in an approved status except for Program of All-Inclusive Care for the Elderly (PACE) plans. This would allow CMS to apply its full Original Medicare enrollment screening process, including identity verification, licensure review, site visits, and fingerprint-based background checks, to providers and suppliers participating in MA. If finalized, this requirement would take effect on the first day of the plan year beginning two years after publication of the final rule.

Risk Adjustment Data Validation (RADV) Program Reforms

The MA RADV program is CMS’ primary way to address overpayments to MA organizations by identifying when there is a lack of documentation in the medical record to support the diagnoses reported for risk adjustment. Specifically, CMS is proposing to codify that it would not apply a fee-for-service (FFS) adjuster, would determine the applicable sampling methodology, and would begin extrapolation of audit findings with payment year (PY) 2018 audits. CMS estimates that this approach would enable the agency to collect an average of approximately $9 billion per payment year in MA program overpayments.

RADV Hardship Exception Process

Currently, the process for granting a hardship exception for medical record submission during a RADV audit exists only in sub-regulatory guidance, without a formal regulatory framework. CMS is proposing to establish a regulatory framework identifying the extraordinary circumstances that would qualify a plan sponsor for a hardship exception, which CMS expects would improve the consistency and transparency of hardship exception determinations.

Medicare DMEPOS Program Integrity

Declining Bonds from Noncompliant Sureties

CMS currently lacks authority to decline a DMEPOS surety bond from a surety company that has previously failed to fulfill its financial obligations to CMS. CMS is proposing a new regulation, modeled on 31 C.F.R. § 223.17(b)(1), establishing a process by which CMS may decline bonds from noncompliant sureties, to protect the Medicare Trust Funds.

DMEPOS Supplier Affiliation Reporting

DMEPOS suppliers are currently required to report owners with a 5% or greater interest, general and limited partners, managing employees, and corporate officers and directors on the Form CMS-855S Medicare enrollment application. CMS is proposing to expand this disclosure requirement to include additional associated entities, such as companies that furnish marketing, fulfillment, wholesale, or device manufacturing services to the supplier. CMS believes this expanded disclosure would help expose interrelated fraudulent network operations.

Redefining “Sufficient Evidence” for Surety Bond Liability

Current regulations (42 C.F.R. § 424.57(a)) define “sufficient evidence” of surety bond liability, but CMS has found that sureties frequently claim the evidence provided is insufficient to avoid their payment obligations. CMS is proposing to revise this definition to include greater detail as to what constitutes “sufficient evidence.” CMS believes this would reduce sureties’ ability to avoid their financial obligations.

Expanding the Prohibition on Unsolicited Beneficiary Contact

Current regulations (42 C.F.R. § 424.57(c)(11)) prohibit DMEPOS suppliers from contacting beneficiaries by telephone without prior permission, subject to limited exceptions, but this prohibition does not extend to email, text messages, social media, or door-to-door contact. CMS is proposing to expand this prohibition to also cover text messages and add new § 424.57(c)(31) to address social media direct messages, email without an opt-out feature, and door-to-door solicitation, subject to the same exceptions that currently apply to telephone contact. CMS believes this expanded protection would better protect beneficiaries from high-pressure marketing and fraudulent solicitation schemes.

Medicaid and CHIP Program Integrity

Reliance on Credible Allegation of Fraud (CAF) Determinations

Under current regulations (42 C.F.R. § 455.23), a state Medicaid agency must suspend payments to a provider upon determining that a credible allegation of fraud (CAF) exists, unless good cause exists not to suspend. CMS cannot currently trigger a state’s obligation to make this determination directly. CMS is proposing to allow states to rely on a CAF determination made by CMS or by another federal agency to establish their own CAF finding under § 455.23(a)(1)(i). CMS is also proposing to narrow the “good cause” exception at § 455.23(e). A state is not required to rely on another agency’s CAF determination; where a state disagrees with a determination CMS has made, CMS encourages the state to engage with CMS’ Center for Program Integrity to better understand the basis for CMS’ determination.

State Fraud and Abuse Reporting Requirements

Current regulations (42 C.F.R. § 455.17), issued in 1978 and amended in 1983, require states to report suspected provider fraud and abuse complaints that warrant full investigation, using six specified data elements. CMS is proposing to add new required data elements, including a provider’s National Provider Identifier (NPI), address and location, and all actions taken against the provider, under § 455.17(b)(6). CMS believes existing requirements no longer provide sufficient detail to support effective national oversight, trend analysis, or coordination between CMS and its state partners.

Electronic Visit Verification (EVV) Enhancements

The 21st Century Cures Act requires states to implement EVV systems for personal care services (PCS) and home health (HH) services, but current regulations do not require states to use EVV data as part of prepayment claims review or preliminary fraud, waste, and abuse investigations. CMS is proposing to modernize these requirements to require that states incorporate EVV information into Medicaid prepayment review activities and preliminary investigations, strengthening oversight in these historically high-risk service areas.

National Provider Identifier Requirements for All Eligible Provider Types

Under current regulations (42 C.F.R. Part 455, Subpart E), states are not required to consistently collect, maintain, or use NPIs across all eligible Medicaid and CHIP provider types, systems, and activities. CMS is proposing to require states to collect, maintain, and use NPIs for all eligible Medicaid and CHIP providers across enrollment, revalidation, claims processing, managed care oversight, program integrity, and reporting activities, consistent with 45 C.F.R. Part 162. CMS believes this would improve the ability of both states and CMS to prevent, identify, and address fraud, waste, and abuse at the individual provider level.

Monthly State Reporting of Provider Denials and Terminations

States are currently required to report “for cause” provider terminations within 30 calendar days, but the rationale for a termination is not always clearly documented, and current reporting excludes providers who were not terminated based on a “best interests” exception. CMS is proposing to require states to submit a monthly report to CMS that includes the legal business name, address, Tax Identification Number, and NPI of any provider denied or terminated (or not denied or terminated under a “best interests” finding) during the applicable reporting period.

New Grounds for Medicaid and CHIP Enrollment Denial and Termination

Current grounds for denying or terminating a provider’s Medicaid or CHIP enrollment are more limited than the grounds available to CMS under Medicare. CMS is proposing to add new grounds for Medicaid and CHIP enrollment denial and termination that mirror several existing Medicare grounds, including felony convictions and revocations based on abusive billing or prescribing practices. CMS believes this alignment would reduce the risk that providers revoked from Medicare could bill Medicaid or CHIP instead.

New Medicaid/CHIP Enrollment Disclosure Requirements

Providers currently must report to states all owners and disclose whether any owner or manager has a criminal conviction related to Medicare, Medicaid, or CHIP participation, but are not required to disclose additional information about owners, managing employees, or adverse legal actions. CMS is proposing to require providers to report this additional information, giving states greater insight into the individuals and entities behind a provider’s operations.

Medicaid Eligibility and Payment Integrity

Replacing the Medicaid Eligibility Quality Control Program

The Medicaid Eligibility Quality Control (MEQC) program, currently codified at 42 C.F.R. § 431.800, has had ongoing deficiencies in flexibility, risk targeting, and timeliness. CMS is proposing to deregulate § 431.800 and, in its place, codify a new Medicaid beneficiary eligibility audit structure consistent with section 1903(u) of the Social Security Act. Unlike the prior state-run MEQC pilots, these audits would be conducted with direct federal oversight of state eligibility determinations, which CMS expects would also reduce administrative burden on states relative to the current MEQC structure. CMS does not anticipate that these eligibility audit obligations would impact beneficiary access to care.

Medicaid Eligibility-Related Disallowances

CMS is proposing to implement disallowances under section 1903(u) of the Social Security Act based on error rates established through the new beneficiary eligibility audits described above, rather than through the Payment Error Rate Measurement (PERM) program. To demonstrate a good-faith effort to meet the statute’s 3% allowable error threshold, a state would need to show that it: (1) implemented the eligibility-related corrective actions in its CMS-approved PERM corrective action plan (CAP); (2) where applicable, made sufficient progress on a CMS-approved CAP responding to prior audit findings; and (3) took additional reasonable actions to prevent, identify, or mitigate eligibility determination errors.

PERM Corrective Action Plan Enhancements

States have not consistently implemented the corrective actions specified in their PERM CAPs. CMS is proposing enhancements to ensure more effective implementation, including a requirement for CMS approval of CAPs and the establishment of a single, combined CAP covering both Medicaid and CHIP corrective actions, which CMS expects would also reduce burden on states.

Program Integrity Corrective Action Plan Requirements

No comprehensive regulatory framework currently exists for corrective action plans addressing findings from CMS program integrity audits. CMS is proposing to establish Program Integrity CAP requirements governing how states develop and implement and how CMS approves and monitors corrective actions resulting from these audits.

Medicaid Fee-for-Service Overpayment Reporting (60-Day Rule)

No regulatory framework currently exists for the timely self-reporting and return of self-identified overpayments in Medicaid fee-for-service (FFS). CMS is proposing to implement statutory requirements for reporting and returning self-identified Medicaid FFS overpayments within 60 calendar days, consistent with existing overpayment reporting requirements already in place for Medicare FFS, Medicare Parts C and D, and Medicaid managed care.

Managed Care Enrollment and Payment Integrity

CMS is proposing to require Medicaid managed care plans to report beneficiary deaths or address changes within 30 days and to return overpayments attributable to individuals who have died or moved out of state.

Request for Information: Protecting Medicaid Payments

As stated at 42 CFR 447.10(i), CMS interprets the payment prohibition in section 1902(a)(32) of the Act to not apply to certain payments made on behalf of individual practitioners for those individual practitioners’ benefits such as health insurance or union dues, in the case of a class of practitioners for which Medicaid is the primary source of revenue and if the practitioner voluntarily consents to the payment. Until now, states have set their own procedures for obtaining that consent. CMS has received reports raising concerns that union dues have been deducted without practitioners’ voluntary consent. To address these concerns, CMS is requesting information from states and other stakeholders about current practices and potential safeguards to ensure that deductions, including for union dues, are made only with the practitioner’s voluntary consent.

Marketplace Program Integrity

New Limitations on Marketplace Participation

Under current regulations (45 C.F.R. § 155.220(g)(1)-(3)), HHS may terminate an agent’s, broker’s, or web-broker’s (A/B) Marketplace agreement(s) after 30 calendar days’ notice, or immediately upon loss of required state licensing, but no authority currently exists to exclude A/Bs based on felony convictions or who have been subjected to adverse actions based on past misconduct related to fraud, waste, and abuse. CMS is proposing to create new limitations on Marketplace participation for A/Bs with certain felony convictions and for adverse actions based on past misconduct.

Clarifying the Standard for Suspension Based on Abusive Conduct

Under current regulations (45 C.F.R. § 155.220(g)(5)), CMS may suspend an A/B’s Marketplace agreement(s) for up to 90 calendar days based on a “reasonable suspicion of fraud” involving personally identifiable information. CMS is proposing to replace this standard with a suspension authority based on a credible allegation of abusive conduct and a finding that the conduct may cause consumer harm, with a 30-calendar day opportunity to refute the allegation. CMS would decide whether to lift the suspension within the 90-calendar day suspension period and would apply a preponderance of the evidence standard for terminations for cause.

Increasing Transparency in Termination-for-Cause Proceedings

Under current regulations (45 C.F.R. § 155.220(g)(1)-(3)), CMS may terminate an A/B’s Marketplace agreement(s) if the A/B does not resolve to CMS’ satisfaction identified noncompliance within 30 calendar days, where that noncompliance is “sufficiently severe.” CMS is proposing to replace the current “opportunity to resolve” standard with an “opportunity to refute,” clarifying that CMS may terminate an A/B’s Marketplace agreement even where the A/B corrects identified noncompliance within the 30-calendar day period, and encouraging earlier A/B participation in the enforcement process. To increase transparency and improve the consistency of enforcement actions, CMS is also proposing to replace the “sufficiently severe” standard with a defined list of factors that CMS may consider when determining whether to terminate an A/B’s Marketplace agreement following a noncompliance finding.

Prohibiting Marketplace System Access from Outside the United States

A/B Marketplace agreements currently prohibit A/Bs from accessing Marketplace systems from outside the United States, but no regulatory provision currently codifies this prohibition. CMS is proposing to codify a regulatory standard prohibiting A/Bs from accessing Marketplace systems from outside the United States, including access from within the United States routed outside the country through a virtual private network (VPN). CMS believes codifying this prohibition would strengthen HHS’ ability to take enforcement action, including termination of an A/B’s Marketplace agreement, against A/Bs found to have accessed or attempted to access Marketplace systems from outside the United States.

Estimated Impacts

CMS estimates that, taken together, the quantified provisions of this proposed rule would result in nearly $90 billion in Federal budget savings and approximately $378.51 million in costs from 2027 to 2036. CMS is seeking public comment on the accuracy of all cost and burden estimates included in this proposed rule.

How to Submit a Comment

CMS will accept public comment on this proposed rule for 60 calendar days following publication in the Federal Register.

For More Information

The CRUSH proposed rule (CMS-6098-P) can be downloaded from the Federal Register at: https://public-inspection.federalregister.gov/2026-23461.pdf

For more information on CMS program integrity efforts, please visit: https://www.cms.gov/medicare/medicaid-coordination/center-program-integrity